Exception from Informed Consent Requirements for Emergency Research: Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 1, 2013
February 3, 2025
c1c4c389-82e0-4459-b587-78c877667c9b
Related Documents
Financial Disclosure by Clinical Investigators: Guidance for Clinical Investigators, Industry,and FDA Staff
Guidance DocumentFebruary 1, 2013Office of the Commissioner
Considerations When Transferring Clinical Investigation Oversight to Another IRB: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentMay 23, 2014Office of the Commissioner
IRB Continuing Review After Clinical Investigation Approval: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentFebruary 27, 2012Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.